about
Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011Vulnerability of homeless people in Tehran, Iran, to HIV, tuberculosis and viral hepatitisTransmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in IranSerum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiencyMagnetic resonance contrast media sensing in vivo molecular imaging agents: an overview.Isolated anti-hbc and occult HBV infection in dialysis patientsPreparation and Evaluation of a New Lipopolysaccharide-based Conjugate as a Vaccine Candidate for Brucellosis.HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest.Neutralizing Antibody Response after Intramuscular Purified Vero Cell Rabies Vaccination (PVRV) in Iranian Patients with Specific Medical Conditions.Expression and Purification of the Uropathogenic Escherichia coli PapG Protein and its Surface Absorption on Lactobacillus reuteri: Implications for Surface Display System Vaccines.Functional recombinant extra membrane loop of human CD20, an alternative of the full length CD20 antigenComparison of Three Different Methods for Detection of IL28 rs12979860 Polymorphisms as a Predictor of Treatment Outcome in Patients with Hepatitis C Virus.Construction and Immunogenicity Analysis of Hepatitis C Virus (HCV) Truncated Non-Structural Protein 3 (NS3) Plasmid Vaccine.Prevalence of Merkel Cell Polyomavirus in Tehran: An Age-Specific Serological StudyPrevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in tehran-iranNovel chlorambucil-conjugated anionic linear-globular PEG-based second-generation dendrimer: in vitro/in vivo improved anticancer activity.Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients.Immunization of Mice by BCG Formulated HCV Core Protein Elicited Higher Th1-Oriented Responses Compared to Pluronic-F127 Copolymer.Role of IL28-B Polymorphism (rs12979860) on Sustained Virological Response to Pegylated Interferon/Ribavirin in Iranian Patients With Chronic Hepatitis C.Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages.Evaluation of Truncated HCV-NS3 Protein for Potential Applications in Immunization and Diagnosis.Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responses.Nanosilver based anionic linear globular dendrimer with a special significant antiretroviral activity.Immunological evaluation of predicted linear B-cell epitopes of human CD20 antigen.Novel molecular anti-colorectalcancer conjugate:chlorambucil-adipic acid dihydrizide-glutamine.Nanosized tamoxifen-porphyrin-glucose [TPG] conjugate: novel selective anti-breast-cancer agent, synthesis and in vitro evaluations.A comparative study of two novel nanosized radiolabeled analogues of methionine for SPECT tumor imaging.Immune responses regulation following antitumor dendritic cell-based prophylactic, concurrent, and therapeutic vaccination.Antiretroviral drug resistance mutations in naïve and experienced patients in Shiraz, Iran, 2014.Impact of null genotypes of GSTT1 and GSTM1 with uterine leiomyoma risk in Iranian population.From in-silico immunogenicity verification to in vitro expression of recombinant Core-NS3 fusion protein of HCV.Conjugated anionic PEG-citrate G2 dendrimer with multi-epitopic HIV-1 vaccine candidate enhance the cellular immune responses in mice.IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C.Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin.Recombinant C-terminal 311 amino acids of HapS adhesin as a vaccine candidate for nontypeable Haemophilus influenzae: A study on immunoreactivity in Balb/C mouse.Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination.MPG-based nanoparticle: An efficient delivery system for enhancing the potency of DNA vaccine expressing HPV16E7.Biodistribution properties of cleistanthin A and cleistanthin B using magnetic resonance imaging in a normal and tumoric animal model.
P50
Q28486583-0B4E9A6C-A9BE-4DE0-81A6-6FBA000ACCA0Q28539374-9F1A1371-9E97-48B7-AD06-D1C448E7F316Q28547171-CF3C29FB-16D0-4617-AD6E-4C240BAA553CQ33768741-C3E2E219-5A67-4DBE-8BFA-28B847A2309AQ34108698-21265CDB-AF00-49D0-9728-F05069775A22Q35089849-BDCFD481-A480-43CF-934C-595CB1096CB5Q35138009-A07F249E-031A-4C2C-9981-812409443B74Q35837172-2C60A090-9F63-44C5-AD86-99E8E46A1920Q36126522-C41F0A99-059F-4B59-8827-55F1FE350C75Q36171857-3C458F59-8199-4201-A121-4A67B6E3A759Q36777171-643C16CB-A88F-4B2D-AB88-D40D77FDEBD5Q36850395-691E0104-6138-4631-A789-9068777D9652Q36928419-5CC0100C-F66E-43AD-8CB3-482C1B714909Q37080822-80E1524C-94A8-4835-8A4E-B5CA5DF06347Q37090963-9CDAD0DC-72E2-4C6A-A73A-0656E3DC7291Q37249045-F0C9ACF6-DC27-4224-B7E5-89277C9826FEQ37347303-52424651-6F6E-4C63-AC46-67778C9563F4Q37347740-B01CD7A5-E275-4240-BB64-F80EA3853EAEQ37597763-56F0BF36-EF1A-496D-A130-200FB4D8FB91Q38152851-302DFD5C-056E-439B-9AB2-9BCEF0C780DEQ38265455-8E90BA31-2504-4263-A54B-D24404F088A4Q38761158-C45FEDDB-0C2C-424B-ABC3-7CA09A362EB7Q38948068-DAEDA5DA-E08F-48C5-A5F6-1278724CF076Q39016168-BB9D84DB-5F6C-48E9-8730-3FD996F6A64AQ39166301-4BC83CF1-18CA-4C3E-AF3F-D2731770FD4CQ39206076-05FAB467-F10E-477E-98A4-DACDCE149B68Q39279666-1DA78E93-B786-4E72-96C5-C978B2AEC28BQ39282187-2373784F-DA5F-4901-9739-1D0ABC709501Q39636912-51F0D043-C4A0-4674-BF53-0293AA1AB2E2Q39638378-CA055469-3CB1-4050-B8AA-376E6E8807B6Q40088115-595F90A7-F382-4C3A-9796-95A8241CEF71Q40215757-0B8F8C3B-0981-4143-A893-37DA9B57BEA9Q40299563-52C0F03A-2A29-49C4-9755-C1590EF9A08DQ40514319-235BB258-B091-49CD-A077-1EA6132962B9Q40545036-A97BD0F0-D98A-4D08-BE55-1A4668B76B79Q40566982-B3E0FCF3-CA8B-43BB-A5D5-84B84E532183Q40667819-0FDB68B6-0BAB-43A2-B6EF-1CDBF7E6B825Q40992209-348E30F8-E1C5-4C98-ABF0-E2EFCD7BD220Q41206969-4FAEDD5B-E20E-4A68-8A8A-1F059FA5E2FCQ42192792-D601BCA4-B467-4861-AC1B-63D89B100B35
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mohammad Reze Aghasadeghi
@ast
Mohammad Reze Aghasadeghi
@de
Mohammad Reze Aghasadeghi
@en
Mohammad Reze Aghasadeghi
@es
Mohammad Reze Aghasadeghi
@nl
Mohammad Reze Aghasadeghi
@sl
type
label
Mohammad Reze Aghasadeghi
@ast
Mohammad Reze Aghasadeghi
@de
Mohammad Reze Aghasadeghi
@en
Mohammad Reze Aghasadeghi
@es
Mohammad Reze Aghasadeghi
@nl
Mohammad Reze Aghasadeghi
@sl
prefLabel
Mohammad Reze Aghasadeghi
@ast
Mohammad Reze Aghasadeghi
@de
Mohammad Reze Aghasadeghi
@en
Mohammad Reze Aghasadeghi
@es
Mohammad Reze Aghasadeghi
@nl
Mohammad Reze Aghasadeghi
@sl
P1053
K-9497-2017
P106
P1153
12789767900
P21
P31
P3829
P496
0000-0003-2186-0774